Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
Condition: Central Diabetes Insipidus (cDI) Interventions: Drug: Intranasal OXT; Other: Placebo nasal spray Sponsor: University Hospital, Basel, Switzerland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Insipidus | Endocrinology | Hospitals | Research | Switzerland Health